{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:59:11Z","timestamp":1790265551878,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014088","name":"AstraZeneca France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014088","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014088","name":"AstraZeneca France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014088","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016912","name":"MSD France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.breast.2020.11.014","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T08:47:20Z","timestamp":1606812440000},"page":"16-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Impact of body mass index on overall survival in patients with metastatic breast cancer"],"prefix":"10.1016","volume":"55","author":[{"given":"Khalil","family":"Saleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6793-3273","authenticated-orcid":false,"given":"Matthieu","family":"Carton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Dieras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Etienne","family":"Heudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Brain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"D\u2019Hondt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Mailliez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Patsouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Ange","family":"Mouret-Reynier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marc","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8505-4387","authenticated-orcid":false,"given":"George","family":"Emile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Uwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Debled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Dalenc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Jouannaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Ladoire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Leheurteur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cottu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Veron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Savignoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralie","family":"Courtinard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Robain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzette","family":"Delaloge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Deluche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2020.11.014_bib1","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Canc"},{"key":"10.1016\/j.breast.2020.11.014_bib2","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.breast.2020.11.014_bib3","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/ijc.29987","article-title":"Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: estimates from the E3N-EPIC cohort","volume":"138","author":"Dartois","year":"2016","journal-title":"Int J Canc"},{"key":"10.1016\/j.breast.2020.11.014_bib4","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ijc.20315","article-title":"Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)","volume":"111","author":"Lahmann","year":"2004","journal-title":"Int J Canc"},{"key":"10.1016\/j.breast.2020.11.014_bib5","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer--viewpoint of the IARC working group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2020.11.014_bib6","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/annonc\/mdh222","article-title":"Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience","volume":"15","author":"Berclaz","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2020.11.014_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.2010.29.7614","article-title":"Effect of obesity on prognosis after early-stage breast cancer","volume":"29","author":"Ewertz","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2020.11.014_bib8","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/annonc\/mdu042","article-title":"Body mass index and survival in women with breast cancer\u2014systematic literature review and meta-analysis of 82 follow-up studies","volume":"25","author":"Chan","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2020.11.014_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1158\/1055-9965.EPI-15-0334-T","article-title":"Body mass index at diagnosis and breast cancer survival prognosis in clinical trial populations from NRG oncology\/NSABP B-30, B-31, B-34, and B-38","volume":"25","author":"Cecchini","year":"2016","journal-title":"Canc Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.breast.2020.11.014_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10549-016-3923-8","article-title":"Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy","volume":"159","author":"Gennari","year":"2016","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.breast.2020.11.014_bib11","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1200\/JCO.2016.68.4480","article-title":"Obesity and breast cancer prognosis: evidence, challenges, and opportunities","volume":"34","author":"Jiralerspong","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2020.11.014_bib12","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1200\/JCO.2003.05.002","article-title":"Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices","volume":"21","author":"Lyman","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2020.11.014_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13058-015-0622-z","article-title":"Leptin produced by obese adipose stromal\/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers","volume":"17","author":"Strong","year":"2015","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2020.11.014_bib14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.canlet.2012.05.019","article-title":"Adipose tissue and breast epithelial cells: a dangerous dynamic duo in breast cancer","volume":"324","author":"Wang","year":"2012","journal-title":"Canc Lett"},{"key":"10.1016\/j.breast.2020.11.014_bib15","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1084\/jem.20181616","article-title":"Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer","volume":"216","author":"Tiwari","year":"2019","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.breast.2020.11.014_bib16","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/523276","article-title":"Obesity is an independent predictor of poor survival in metastatic breast cancer: retrospective analysis of a patient cohort whose treatment included high-dose chemotherapy and autologous stem cell support","volume":"2011","author":"von Drygalski","year":"2011","journal-title":"Int J Breast Cancer"},{"key":"10.1016\/j.breast.2020.11.014_bib17","article-title":"Impact of BMI on clinical outcome of HER2-positive breast cancer","volume":"28","author":"Parolin","year":"2010","journal-title":"J\u00a0Clin Orthod"},{"key":"10.1016\/j.breast.2020.11.014_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.critrevonc.2018.06.011","article-title":"Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer","volume":"129","author":"Trestini","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.breast.2020.11.014_bib19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.breast.2017.11.004","article-title":"Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer","volume":"37","author":"Martel","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.breast.2020.11.014_bib20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/15384047.2017.1416938","article-title":"Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab","volume":"19","author":"Pizzuti","year":"2018","journal-title":"Canc Biol Ther"},{"key":"10.1016\/j.breast.2020.11.014_bib21","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1158\/1055-9965.EPI-13-0595","article-title":"Body mass index and prognosis of metastatic breast cancer patients receiving first-line chemotherapy","volume":"22","author":"Gennari","year":"2013","journal-title":"Canc Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.breast.2020.11.014_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023568","article-title":"The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)","volume":"9","author":"P\u00e9rol","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.breast.2020.11.014_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejca.2020.01.016","article-title":"Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016","volume":"129","author":"Deluche","year":"2020","journal-title":"Eur J Canc"},{"key":"10.1016\/j.breast.2020.11.014_bib24","series-title":"D\u00e9ontologie et bonnes pratiques en \u00e9pid\u00e9miologie, recommendations r\u00e9vis\u00e9es","author":"Association des Epid\u00e9miologistes de Langue Fran\u00e7aise (ADELF)","year":"2007"},{"key":"10.1016\/j.breast.2020.11.014_bib25","series-title":"Guidelines for good pharmacoepidemiology practices","year":"2015"},{"key":"10.1016\/j.breast.2020.11.014_bib26","article-title":"Clinical implications of body mass index in metastatic breast cancer patients treated with abemaciclib and endocrine therapy","author":"Franzoi","year":"2020","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2020.11.014_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.2010.29.7614","article-title":"Effect of obesity on prognosis after early-stage breast cancer","volume":"29","author":"Ewertz","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2020.11.014_bib28","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/annonc\/mdu042","article-title":"Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies","volume":"25","author":"Chan","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2020.11.014_bib29","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/cam4.634","article-title":"Overweight and obesity predict better overall survival rates in cancer patients with distant metastases","volume":"5","author":"Tsang","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.breast.2020.11.014_bib30","first-page":"103","article-title":"Factors associated with mortality after breast cancer metastasis","volume":"23","author":"Jung","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.breast.2020.11.014_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2019-000562","article-title":"UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO)","volume":"4","author":"Vaz-Luis","year":"2019","journal-title":"ESMO Open"},{"key":"10.1016\/j.breast.2020.11.014_bib32","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/jamaoncol.2018.0137","article-title":"Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer","volume":"4","author":"Caan","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.breast.2020.11.014_bib33","article-title":"Prognostic significance of sarcopenia in patients with unresectable Advanced esophageal cancer","volume":"8","author":"Onishi","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.breast.2020.11.014_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2015.12.030","article-title":"Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review","volume":"57","author":"Shachar","year":"2016","journal-title":"Eur J Canc"},{"key":"10.1016\/j.breast.2020.11.014_bib35","first-page":"100154","article-title":"Evaluation of body Computed Tomography-determined sarcopenia in breast cancer patients and clinical outcomes: a systematic review","volume":"21","author":"Rossi","year":"2019","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.breast.2020.11.014_bib36","first-page":"861","article-title":"Impact of body composition on outcome in patients with early breast cancer","volume":"26","author":"Deluche","year":"2018","journal-title":"Support Care Canc"},{"key":"10.1016\/j.breast.2020.11.014_bib37","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1158\/1078-0432.CCR-16-0940","article-title":"Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy","volume":"23","author":"Shachar","year":"2017","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.breast.2020.11.014_bib38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10549-017-4574-0","article-title":"Changes in body composition and muscle attenuation during taxane-based chemotherapy in patients with metastatic breast cancer","volume":"168","author":"Rier","year":"2018","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.breast.2020.11.014_bib39","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.breast.2020.11.014_bib40","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/jamaoncol.2018.0137","article-title":"Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer","volume":"4","author":"Caan","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.breast.2020.11.014_bib41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1470-2045(18)30077-9","article-title":"BMI and outcomes in melanoma: more evidence for the obesity paradox","volume":"19","author":"Hayes","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2020.11.014_bib42","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ijc.27639","article-title":"Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis","volume":"132","author":"Choi","year":"2013","journal-title":"Int J Canc"},{"key":"10.1016\/j.breast.2020.11.014_bib43","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13104-017-2876-2","article-title":"The impact of baseline body mass index on clinical outcomes in metastatic breast cancer: a prospective study","volume":"10","author":"Alarfi","year":"2017","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.breast.2020.11.014_bib44","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1158\/0008-5472.CAN-17-3287","article-title":"The importance of body composition in explaining the overweight paradox in cancer\u2014counterpoint","volume":"78","author":"Caan","year":"2018","journal-title":"Canc Res"},{"key":"10.1016\/j.breast.2020.11.014_bib45","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/1055-9965.EPI-17-0200","article-title":"Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS study)","volume":"26","author":"Caan","year":"2017","journal-title":"Canc Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.breast.2020.11.014_bib46","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1177\/1060028020902318","article-title":"Pharmacokinetics of trastuzumab after subcutaneous and intravenous administration in obese patients","volume":"54","author":"Gonz\u00e1lez Garc\u00eda","year":"2020","journal-title":"Ann Pharmacother"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977620302204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977620302204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:42:02Z","timestamp":1760776922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977620302204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":46,"alternative-id":["S0960977620302204"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2020.11.014","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of body mass index on overall survival in patients with metastatic breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2020.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}